Mrs Casey Hammond, DPT | |
544 Yellowstone Ave, Cody, WY 82414-9300 | |
(307) 587-9789 | |
(307) 587-9787 |
Full Name | Mrs Casey Hammond |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 544 Yellowstone Ave, Cody, Wyoming |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1871226142 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 2172 (Wyoming) | Primary |
Provider Name | Canyon Hand Therapy, P.c. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1639476443 PECOS PAC ID: 6901088020 Enrollment ID: O20110310000987 |
News Archive
UI Heart Care researchers are among the first in the nation to evaluate the effectiveness of cardiac resynchronization therapy (CRT) devices to reduce the risk of mortality and hospitalization in advanced heart failure patients.
Young patients who underwent surgery for isolated meniscus tears between 1990 and 2005 showed positive long-term clinical results, according to new research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego.
Connecticut Children's Medical Center and Anthem Blue Cross and Blue Shield announced today that they have reached a multi-year agreement, ending a two-month dispute that led to uncertainty and confusion for many patients and their families. The hospital and the Connecticut Children's Specialty Group had dropped the insurer April 16 after both sides failed to reach an agreement after a year of negotiations. Under the deal, Anthem will immediately resume covering in-network costs.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics' weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave's approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel's recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Casey Hammond, DPT 544 Yellowstone Ave, Cody, WY 82414-9300 Ph: (307) 587-9789 | Mrs Casey Hammond, DPT 544 Yellowstone Ave, Cody, WY 82414-9300 Ph: (307) 587-9789 |
News Archive
UI Heart Care researchers are among the first in the nation to evaluate the effectiveness of cardiac resynchronization therapy (CRT) devices to reduce the risk of mortality and hospitalization in advanced heart failure patients.
Young patients who underwent surgery for isolated meniscus tears between 1990 and 2005 showed positive long-term clinical results, according to new research presented today at the American Orthopaedic Society for Sports Medicine's Annual Meeting in San Diego.
Connecticut Children's Medical Center and Anthem Blue Cross and Blue Shield announced today that they have reached a multi-year agreement, ending a two-month dispute that led to uncertainty and confusion for many patients and their families. The hospital and the Connecticut Children's Specialty Group had dropped the insurer April 16 after both sides failed to reach an agreement after a year of negotiations. Under the deal, Anthem will immediately resume covering in-network costs.
Research led by Dr. Suresh Alahari, Professor of Biochemistry and Molecular Biology at LSU Health Sciences Center New Orleans, is the first to report that two specific tumor suppressor genes work in concert to inhibit the growth and spread of breast tumor cells to the lungs.
A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics' weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave's approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel's recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.
› Verified 9 days ago
Nia Marie Torres, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2456 Carter Ave, Cody, WY 82414 Phone: 575-779-5895 | |
Kristen Michelle Goldberg, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 544 Yellowstone Ave, Cody, WY 82414 Phone: 307-587-9789 Fax: 307-587-9787 | |
Lori Grubbs Swanton, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1130 Sheridan Ave Ste 210, Cody, WY 82414 Phone: 307-213-9595 Fax: 307-939-2249 | |
Timothy P Stecker, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 720 Lindsay Ln, Cody, WY 82414 Phone: 307-578-1970 Fax: 307-578-1973 | |
Gail Ann Mills, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 702 Platinum Dr, Cody, WY 82414 Phone: 307-578-7883 Fax: 307-586-2350 | |
Lacy Martin, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 544 Yellowstone Ave, Cody, WY 82414 Phone: 307-587-9789 Fax: 307-587-9787 | |
Adam K Johnnidis, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 720 Lindsay Ln, Cody, WY 82414 Phone: 307-578-1970 |